Business Wire › October 27, 1999
Linked as:Extract
Apollo BioPharmaceutics, a CNS Development Company, Retains Adams, Harkness & Hill to Explore Strategic Alternatives.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 27, 1999--
Apollo BioPharmaceutics, Inc...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Minimal Improvement in Adolescent and Young Adult (AYA) Cancer Patients' Survival Rate. | higher education funding takes hit | dana strickland, a mechanic, walks through the branford public works department...[derived headline; caption text only] | Local Online Advertising Leader Yodle Announces Completion of $10 Million Series D Financ... | Sentencia nº 4976 de Consiglio di Stato September 23 2008 | Sentencia nº 6687 de Consiglio di Stato December 18 2007 | Sentencia nº 6309 de Consiglio di Stato, November 26, 2008 | Sentencia nº 3358 de Consiglio di Stato, July 21, 2010
